Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis

Carter, Melody C., Robyn, Jamie A., Bressler, Peter B., Walker, John C., Shapiro, Gail G., Metcalfe, Dean D.·2007·Journal of Allergy and Clinical Immunology
DOI 10.1016/j.jaci.2007.03.032

Cited by (172)

Items 101–172 of 172

  1. Long-term Treatment of Severe Recalcitrant Atopic Dermatitis with Omalizumab, an Anti-immuno-globulin E
    Sven Quist, Andreas Ambach, Daniela Göppner, J Quist, Ingolf Franke, Bernd Bonnekoh, Harald P. M. Gollnick · 2013 · Acta Dermato Venereologica
  2. Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis
    Noelia Dasilva, Andrea Mayado, Cristina Teodósio, María Jara‐Acevedo, Iván Álvarez‐Twöse, Almudena Matito, Laura Sánchez‐Muñoz, Carolina Caldas, Ana Henriques, Javier I. Muñoz‐González et al. · 2019 · International Journal of Molecular Sciences
  3. A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders
    Jan Romantowski, Aleksandra Górska, Marek Niedoszytko, Theo Gülen, Marta Gruchała‐Niedoszytko, Bogusław Nedoszytko, Magdalena Lange, Knut Brockow, Michel Arock, Cem Akin et al. · 2021 · International Journal of Molecular Sciences
  4. Omalizumab for mast cell disorders
    Cem Akin · 2024 · Journal of Allergy and Clinical Immunology
  5. Akuttherapie und Management der Anaphylaxie
    Knut Brockow, Johannes Ring · 2013 · Der Hautarzt
  6. New Indications of Biological Drugs in Allergic and Immunological Disorders: Beyond Asthma, Urticaria, and Atopic Dermatitis
    Daniele Russo, Paola Di Filippo, Sabrina Di Pillo, Francesco Chiarelli, Marina Attanasi · 2023 · Biomedicines
  7. Cardiovascular symptoms in patients with systemic mast cell activation disease
    Ulrich W. Kolck, Britta Haenisch, Gerhard Josef Molderings · 2015 · Translational research
  8. Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 2: Etanercept, Efalizumab, Alefacept, Rituximab, Daclizumab, Basiliximab, Omalizumab, and Cetuximab
    G. Guhl, Blanca Díaz-Ley, Jesús Fernández‐Herrera · 2008 · Actas Dermo-Sifiliográficas
  9. Omalizumab and mast cell disorders: are we there yet?
    Weiler, Catherine R. · 2019 · The Journal of Allergy and Clinical Immunology In Practice
  10. Biologicals for the prevention of anaphylaxis
    Luciana Kase Tanno, Pascal M. Demoly · 2021 · Current Opinion in Allergy and Clinical Immunology
  11. Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy
    Elisa Meucci, Anna Radice, Filippo Fassio, Maria Loredana Iorno, Donatella Macchia · 2021 · Clinical Case Reports
  12. Target Therapies for Systemic Mastocytosis: An Update
    Mariarita Sciumé, Claudio De Magistris, Nicole Galli, Eleonora Ferretti, Giulia Milesi, Pasquale De Roberto, Sonia Fabris, Federica Irene Grifoni · 2022 · Pharmaceuticals
  13. Exercise-Induced Anaphylaxis: A Case Report and Review of the Diagnosis and Treatment of a Rare but Potentially Life-Threatening Syndrome
    Nathan T. Jaqua, Matthew R. Peterson, Karla L. Davis · 2013 · Case Reports in Medicine
  14. Biologics as treatment options for anaphylaxis
    Arianna Cafarotti, Alessandro Giovanni Fiocchi, Stefania Arasi · 2021 · Current Opinion in Allergy and Clinical Immunology
  15. Biologic Agents for the Treatment of Anaphylaxis
    Luciana Kase Tanno, Bryan L Martin · 2020 · Immunology and Allergy Clinics of North America
  16. Successful treatment with Omalizumab of a child affected by Systemic Mastocytosis: clinical and biological implications
    Grazia Bossi, Valeria Brazzelli, Mara DE AMICI, Daniela Pietra, Chiara Raviola, Matteo Naso, Corrado Regalbuto, Federica Boselli, Valeria Fortina, Gian Luigi Marseglia · 2023 · The Italian Journal of Pediatrics/Italian journal of pediatrics
  17. Management of adult mastocytosis
    Iván Álvarez‐Twöse, Almudena Matito, Laura Sánchez‐Muñoz, José Mário Morgado, Luís Escribano · 2014 · Expert Opinion on Orphan Drugs
  18. Anaphylaxis in Mastocytosis
    Luís Escribano, Alberto Órfão · 2010 · Humana Press eBooks
  19. Case Report: Mastocytosis: The Long Road to Diagnosis
    Tiago Azenha Rama, Diana F. Martins, Nuno Preto Gomes, Jorge Pinheiro, Ana Nogueira, Luís Delgado, José Luís Plácido, Alice Coimbra · 2021 · Frontiers in Immunology
  20. Diffuse Cutaneous Mastocytosis with Bullous Lesions and Pulmonary Involvement: A Rare Case
    Sandipan Dhar, Biplab Maji, Roy Sk, Subhra Dhar · 2015 · Indian Journal of Dermatology
  21. Successful prevention of severe allergic transfusion reactions with omalizumab
    Sensen Shi, Jingjing Han, Yao Yao, Yang Xu, Depei Wu, Ying Wang · 2020 · Transfusion
  22. New treatments for systemic mastocytosis in 2025
    Giovanni Costanzo, Valentina Marzio, Edoardo Cavaglià, Giovanni Paoletti, Enrico Marco Heffler · 2025 · Current Opinion in Allergy and Clinical Immunology
  23. Management of indolent mastocytosis and mast cell activation syndrome
    Cem Akin, Joseph H. Butterfield, Mariana Castells, Jonathan J. Lyons · 2025 · Annals of Allergy Asthma & Immunology
  24. Management of Idiopathic Anaphylaxis: When Is Bone Marrow Examination Essential?
    Jim M. Fernandez, Cem Akin · 2014 · Current Treatment Options in Allergy
  25. Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case series
    Marco Caminati, Elisa Olivieri, Francesca Nalin, Roberta Zanotti, Gianenrico Senna, Michele Schiappoli, Annarita Dama, Patrizia Bonadonna · 2019 · European Journal of Internal Medicine
  26. Pediatric Mastocytosis
    Nisha Suyien Chandran · 2015 · Springer eBooks
  27. Systemic Mastocytosis
    Bárbara Martínez, Dean D. Metcalfe, Todd M. Wilson · 2009 · CRC Press eBooks
  28. Long-Term Successful Treatment of Indolent Systemic Mastocytosis With Omalizumab
    Samuel L Weiss · 2021 · Federal Practitioner
  29. Omalizumab, Recombinant Humanized Monoclonal Antibody Anti-IgE—New Fields of Studies on the Therapeutic Indications
    Izabela R. Kuprys-Lipinska, Piotr Kuna · 2008 · Advances in respiratory medicine
  30. Neues zur Therapie der Mastozytose
    Knut Brockow, Martine Grosber, K. Hölzle, Heidrun Behrendt, Johannes Ring · 2009 · Aktuelle Dermatologie
  31. Pediatric Mastocytosis
    Julianne A. Mann, Sabra Leitenberger, Alfons L. Krol · 2013 · Springer eBooks
  32. Expanding indications of omalizumab therapy in the absence of specific IgE
    Sujoy Khan, Sarah J. Deacock · 2011 · Allergologia et Immunopathologia
  33. Anaphylaxis in Mastocytosis
    Theo Gülen, Joanne N.G. Oude Elberink, Knut Brockow · 2019 · Springer eBooks
  34. Mast Cell Disorders
    Joyce E. Yu, Cem Akin · 2016 · The Journal of Allergy and Clinical Immunology In Practice
  35. Management of Anaphylaxis: Relevance of Causes and Future Trends in Treatment
    Scott P. Commins, Thomas A.E. Platts‐Mills · 2010 · Humana Press eBooks
  36. Mastozytose – Diagnostisches und therapeutisches Management
    N. Wagner, Karin Hartmann · 2011 · Aktuelle Dermatologie
  37. Dystonia as an unusual presentation of systemic mastocytosis: Possible link between histamine release and movement disorders
    Alexandra Phillips, Flavia Cecilia Lega Hoyte, Donald Y.M. Leung · 2017 · The Journal of Allergy and Clinical Immunology In Practice
  38. A case of omalizumab as a successful treatment for telangiectasia macularis eruptiva perstans
    Alexandra M. Mortimore, Ramez Barsoum, Duncan Lambie, Erin McMeniman · 2021 · Australasian Journal of Dermatology
  39. Predictive value of the systemic immune inflammation index and systemic inflammatory response index on omalizumab drug survival in chronic spontaneous urticaria
    Adriano Fabi, Stefan Milosavljevic, Claudia Cécile Valérie Lang, Carole Guillet, Peter Schmid‐Grendelmeier · 2023 · Allergo Journal International
  40. Mastocytosis: A New Therapeutic Scenario with Omalizumab
    Zampetti Anna · 2018 · International Journal of Allergy Medications
  41. Mastocytosis: Overview of Diagnosis and Classification
    Cem Akin, Sigurd Broesby‐Olsen, Peter Valent · 2019 · Springer eBooks
  42. Omalizumab: a broader role in dermatology? Evidence and the road ahead
    Aditya Kumar Bubna, Vinayak Viplav · 2025 · Italian Journal of Dermatology and Venereology
  43. Cardiovascular manifestations in mast cell activation disease: key insights for cardiologists and angiologists
    Wolfgang Taumann, Gerhard Josef Molderings · 2025 · Frontiers in Cardiovascular Medicine
  44. Omalizumab for Pediatric Cutaneous Mastocytosis: Case Report and Review
    Janis Chang, Aliyah King, Adam Byrne, Carmen Liy‐Wong · 2025 · Pediatric Dermatology
  45. Skin Disease in Mastocytosis
    Zita‐Rose Manjaly Thomas, Karin Hartmann · 2019 · Springer eBooks
  46. Omalizumab Therapy for Allergic Diseases
    2013 · BENTHAM SCIENCE PUBLISHERS eBooks
  47. Omalizumab Treatment for Prevention of Anaphylaxis
    Hector Rodriguez, John M. Fahrenholz · 2014 · Current Treatment Options in Allergy
  48. Urticaria pigmentosa: cutaneous mastocytosis in a child
    Claudia Salvini B.M. da Fonseca, Elisângela Ferreira Vasconcellos, Juliana Salvini Barbosa Martins da Fonseca, Raquel Machado Barbosa, Vivian Cristine Santos Oliveira · 2013 · Brazilian Journal of Allergy and Immunology (BJAI)
  49. Omalizumab en indicaciones diferentes al asma alérgica
    Luis Pérez de Llano, Antonio Parra Arrondo · 2015 · Monografías de Archivos de Bronconeumología
  50. GDAŃSKI UNIWERSYTET MEDYCZNY
    Marcin Renke · 2009
  51. Letter to the editor
    Kalliopi Kontou-Fili · 2009 · Allergy
  52. Management of Idiopathic Anaphylaxis: When Is Bone Marrow Examination
    Cem Akin · 2014
  53. Neue Entwicklungen bei anti allergischen Therapien und Therapiekonzepten
    Tilo Biedermann, Martin Röcken, Harald E. Renz · 2016
  54. Anti-IgE Therapy
    Andrea D. Maderal, Brian Berman · 2017 · Springer eBooks
  55. The Recurrent Flush: A Case and Review of Systemic Mastocytosis
    Wasim Mansoor, Shaan Chugh, Carlo V. Hojilla, Rashmi S. Goswami, Rodrigo B. Cavalcanti · 2018 · Canadian Journal of General Internal Medicine
  56. Mast Cell Disorders and Anaphylaxis
    S. Alagheband, Catherine Cranford, Patricia H. Stewart · 2019 · Springer eBooks
  57. Management of Anaphylaxis Refractory to Standard First Line Therapy
    Catherine M. Hammond, Phil Lieberman · 2020 · Springer eBooks
  58. Diagnostyka i leczenie mastocytozy układowej — stanowisko ekspertów
    Marek Hus, Aneta Szudy‐Szczyrek, Grzegorz Helbig, Tomasz Sacha, Andrzej Mital, Bożena Katarzyna Budziszewska, Monika Prochorec‐Sobieszek, Krystyna Gałązka · 2020 · Hematologia
  59. Prise en charge diagnostique et thérapeutique des syndromes d’activation mastocytaire
    Evangéline Clark, Aurélie Schiffmann, Alexandre Jentzer, Pascal M. Demoly, Philippe Guilpain, Davide Paolo Caimmi · 2021 · Revue française d'allergologie
  60. Mast Cell Disorders and Anaphylaxis
    S. Alagheband, Catherine Cranford, Patricia H. Stewart · 2019 · Springer eBooks
  61. Reply
    Melody C. Carter · 2010 · Journal of Allergy and Clinical Immunology
  62. Innovative Therapeutic Approaches in Systemic Mastocytosis: an Updated Review
    Delia Soare, Poliana Mihaela Leru, Horia Bumbea · 2025 · MAEDICA – a Journal of Clinical Medicine
  63. Using Biologics in the Prevention of Anaphylaxis
    Daniel Y. Song, Amika Sood, Stephen A. Schworer, Onyinye I. Iweala, Mildred Kwan · 2025 · Current Allergy and Asthma Reports
  64. Clinical efficacy and safety of omalizumab in patients with mastocytosis: a systematic review and meta-analysis
    Ahmad M. Molhem, Raneem Aldamen, Amr Taher Masoud, Qussai R. Abuelsamen, Fai Mubarak Alsaleeli, Omar M. Almomani, Ayah E. Shawaqfeh, H. Flye Sainte Marie, Rama A. AlHomoud, Mujahed Nabeel Ibrahim Beitho et al. · 2025 · Archives of Dermatological Research
  65. Omalizumab
    Aditya Kumar Bubna · 2025 · Springer eBooks
  66. Mastocytosis and insect venom allergy: a special relationship
    Frank Siebenhaar, Nicole Nojarov, Polina Pyatilova · 2025 · Allergo Journal International
  67. Mastozytose und Insektengiftallergien: eine besondere klinische Konstellation
    Frank Siebenhaar, Nicole Nojarov, Polina Pyatilova · 2026 · Allergo Journal
  68. Characterizing the role of IgG antibodies in anaphylaxis
    Bianca Balbino · 2019 · theses.fr (ABES)
  69. Antibodies against Neuromuscular Blocking agents in allergic patients : from mechanisms to therapeutics
    Alice Dejoux · 2024
  70. Smoldering Systemic Mastocytosis Without Detectable KIT Mutation: A Debilitating Course and Therapeutic Challenge
    Anna Homeniuk, Medina Esenbekova, Micheal Bishara, Layo Akinrinwoye, Leila Metellus, Joane Titus · 2026 · Cancer Nexus
  71. Advances in the Management of Mediator-Related Symptoms in Non-Advanced Systemic Mastocytosis
    Theo Gülen, Vito Sabato · 2026 · ImmunoTargets and Therapy
  72. Repositioning omalizumab in dermatology: emerging indications and mechanism-based therapeutic insights
    Sunil Dogra, Sahibpreet Kaur, Muthu Sendhil Kumaran · 2026 · Expert Opinion on Biological Therapy